Do joint supplements work? A short answer first
The level of evidence for nutritional supplements used for osteoarthritis in dogs differs by ingredient. Omega-3 (fatty acids such as EPA and DHA) was reported in systematic reviews to have the relatively most distinct evidence for a pain-relieving effect in dogs. By contrast, in a 2022 systematic review and meta-analysis an effect of glucosamine and chondroitin was not confirmed, and the authors concluded that they are no longer recommended for pain management.
The levels of evidence in this article are divided, in order, into public agency guidance, systematic reviews and randomized controlled studies, small studies, industry claims, and lack of evidence. The key point is that in a review that gathered clinical trials in dogs and cats, an effect of glucosamine and chondroitin was not confirmed.
However, saying that “the evidence is weak” does not mean “it is necessarily harmful.” It is closer to saying that an effect has not been demonstrated, and whether it suits my pet depends on the individual's age, weight, joint condition, and the medication it is taking. So this article is not guidance on which product to choose; it organizes how to read the evidence and what to do first.
Also, signs of joint discomfort (limping, hesitating when getting up, avoiding stairs, and so on) may not be a problem to solve with a supplement but a problem whose cause needs to be identified through a veterinary visit. A supplement can be seen as one of the options that may be considered at the next stage, after consulting a veterinarian.
The level of evidence by ingredient, in a table
The table below organizes only what I confirmed by directly opening the abstracts of two systematic reviews published on PubMed. This article did not re-evaluate each individual clinical trial; it only conveys the conclusions reached by the review authors.
The 2022 review (Barbeau-Grégoire et al., International Journal of Molecular Sciences) is a systematic review and meta-analysis registered in PROSPERO, and the abstract states that it gathered 1,578 records from 4 electronic databases and 20 internal records, and analyzed 57 papers and 72 trials divided into 9 categories of natural health products. The authors disclosed a history of working with several animal pharmaceutical and feed companies, and wrote that there were no conflicts of interest directly related to this review. In this analysis it was reported that the evidence of a pain-relieving effect was distinct for omega-3-enriched diets, omega-3 supplements, and cannabidiol (to a lesser degree), that collagen had a weak effect, and that the glucosamine-chondroitin category very clearly had no effect.
The 2012 review (Journal of Veterinary Internal Medicine) examined 22 papers on horses, dogs, and cats, and concluded that the strength of evidence for all nutritional supplements other than omega-3 is low in dogs. This review also pointed out as a limitation that the number of randomized controlled trials and the number of animals taking part in the trials were insufficient.
The Merck Veterinary Manual (professional version) explains that commercial glucosamine-chondroitin products may contain other ingredients as well, so it is also worth remembering that it is hard to read the result for one product as the effect of one ingredient. This article followed the category names the reviews used as they were, and did not evaluate individual products.
| Ingredient | Form of evidence confirmed | Conclusion of the review | This article's evidence level category |
|---|---|---|---|
| Omega-3 (EPA, DHA) | 2022 systematic review and meta-analysis, 2012 systematic review | Reported distinct evidence of a pain-relieving effect (2022). The only ingredient in dogs whose strength of evidence is not low (2012) | Based on systematic reviews and randomized controlled trials |
| Glucosamine-chondroitin combination | 2022 systematic review and meta-analysis | No effect very clearly, and the authors' conclusion that it is no longer recommended for pain management | Effect not confirmed in a systematic review |
| Collagen | 2022 systematic review and meta-analysis | Reported a weak effect | Weak evidence |
| Cannabidiol (for reference) | 2022 systematic review and meta-analysis | Reported a pain-relieving effect, though to a lesser degree. Korean regulation and safety were not checked in this article | Evidence exists, but outside the scope of this article |
| Other ingredients | 2012 systematic review | Reported low strength of evidence in dogs other than omega-3 | Lack of evidence |
Why do these differences arise? How to read the evidence
Even for the same ingredient, the strength of the conclusion can differ from review to review. The 2012 review cited as a limitation that the number of strictly designed randomized controlled trials and the number of animals taking part were limited, and the 2022 review wrote in its abstract that it evaluated the effect while also weighing the quality level of each trial.
A systematic review is a method of gathering and evaluating several trials using a set search method (both reviews state in their abstracts the databases they searched). However, a review also reflects only “the trials published up to that point,” so if better-designed trials appear later, the conclusion may change. The most recent review this article confirmed was published in 2022.
Another point to distinguish is that “it has an effect” and “it changes joint structure” are different statements. The 2022 review used clinical pain relief as its criterion, that is, whether the degree to which the animal looked to be in pain decreased. A claim that something protects cartilage or slows the progression of arthritis needs separate evidence.
Finally, the intent of the FDA guidance is also worth noting. The FDA explains that a product that claims to improve joint function is meant to affect the body's function in a way other than nutrition, so it may qualify as an animal drug. That is, the logic is that the moment a product claims to improve joints, it must be evaluated by the standards of a “drug,” not “nutrition.”
How do supplements and veterinary drugs differ in Korea?
MAFRA says that it treats an item used to diagnose, treat, alleviate, manage, or prevent disease in animals as a veterinary drug. The same guidance says that the import business report and the product approval or report for veterinary drugs are to be made to the Animal and Plant Quarantine Agency (APQA), and that a product approved as a drug and a product that is not differ in legal nature.
The same MAFRA and APQA guidance (attached card news) lists, as prohibited expressions in online sales, expressions such as treatments for joint disease, atopic dermatitis, anticancer drugs, and treatments for heart failure and kidney failure in pets, and false or exaggerated advertising of medical efficacy for items that are not veterinary drugs. Accordingly, a phrase such as “treatment for joint disease” on an ordinary supplement sales page may fall under the prohibited expressions in the guidance.
So under what system are supplements? Daily Vet, a specialist outlet in Korea, reporting a Korea Consumer Agency survey and the researchers' opinion, reported that pet supplements are currently not managed as a separate category like human health functional foods but are managed as feed (complementary feed) under the Control of Livestock and Fish Feed Act (사료관리법). The first author of the paper that this article reported on is the head of the technical regulation subcommittee of the Korea Pet Food Association, so it should be read with the point in mind that it is the opinion of researchers affiliated with an industry group. MAFRA also stated in a press release of August 20, 2026 that under current law it does not classify pet food separately as supplements or functional supplements, and divides it under the Control of Livestock and Fish Feed Act into single-ingredient feed, complementary feed, and formula feed. However, neither source is the text of the law, so for the exact wording of the legal provisions it is good to check the current Control of Livestock and Fish Feed Act directly at the National Law Information Center. This article did not open and read the legal provisions themselves.
According to the same report, the Korea Consumer Agency surveyed 20 pet supplements sold online and offline, and in 8 products the ingredient labeled as a functional ingredient was not detected or only 1–38% of the labeled amount was detected. Of 100 online advertisements, 67 emphasized disease prevention or treatment effects without scientific evidence, raising the concern that they could be mistaken for veterinary drugs. These are figures confirmed through a media report, not the Korea Consumer Agency's original document.
How do US and Korean standards differ?
The US FDA explains that animal supplements are not covered by the Dietary Supplement Health and Education Act (DSHEA), which applies to humans. The FDA does not recognize animal supplements as a separate category, and treats them as either animal food or animal drugs depending on the product's ingredients and intended use. The distinction is that something that affects the body's structure or function through nutrition, taste, or aroma is food, while something that treats or prevents disease, or is intended to affect the body's function in a way other than nutrition, is a drug.
As an example of this distinction, the FDA places a product that improves joint function in a dog with arthritis on the drug side. It also gives the example that chondroitin sulfate, if sold for preventing or treating arthritis in pets, becomes a drug and therefore cannot be subject to Generally Recognized as Safe (GRAS) status as a feed ingredient. That is, in the US, even if a product carries the name “supplement,” legally it is either feed or a drug.
In the US there is an industry group, the National Animal Supplement Council (NASC). The NASC website's guidance on its quality seal explains that a member company can use the seal only if it passes an independent quality audit and continuously keeps standards such as a quality control manual, an adverse event reporting system, compliance with labeling guidelines, and random product testing by an independent laboratory (checking that the contents match the label). This seal is not a government-approved guarantee of efficacy but a voluntary industry system. The website does not address whether government regulations require participation, and the presence of the seal does not mean joint effects have been demonstrated.
Korea looks similar to the US in having two tracks, complementary feed (feed) and veterinary drugs, but the detailed systems differ. This article could not compare the detailed differences between the Korean and US systems against the text of the laws. When buying an overseas product directly, it is enough to remember only that an overseas certification seal does not replace approval or inspection under the Korean system.
What should guardians check?
A guardian considering a joint supplement can first check the following on the product package or sales page. The items below are not guidance on choosing a product but criteria for reading advertising claims.
- Whether it claims to treat or prevent disease: if there is a phrase such as treating arthritis, it is an expression that can be mistaken for a veterinary drug and may conflict with MAFRA's guidance.
- What the evidence for the ingredient is: distinguish whether there is a systematic review or randomized controlled trial on that ingredient, or only the manufacturer's explanation.
- Whether the content amount is stated: a case was reported in the Korea Consumer Agency survey in which the labeled functional ingredient was not detected, so keep in mind that the label and the actual content can differ.
- The nature of an industry certification seal: a seal such as the US NASC is a voluntary industry system and not a guarantee of efficacy.
- Whether other ingredients are included: with a combination product it is hard to know which ingredient is acting, and it may overlap with medication being taken.
- Whether it overlaps with medication or food already being given: show the veterinarian whether it duplicates prescription drugs, food that already contains omega-3, or other supplements.
Weight is something to look after alongside this. The Merck Veterinary Manual explains that optimizing body weight is the main preventive method for slowing the progression of osteoarthritis in dogs and is essential if the dog is overweight. Weight control reduces the load on the joints itself, so it is treated not as something comparable to a supplement but as something to do first.
Weight management and body condition score checks are covered in a separate article (pet-obesity-body-condition-score), so they are not explained in detail here.
What are common misconceptions about joint supplements?
The first misconception is the idea that “because it is an ingredient in joint supplements that people take, it has the same effect in pets.” The media reported that researchers in Korea (including the first author affiliated with the Korea Pet Food Association) considered that pets and humans differ in absorption and metabolism, so it is hard to apply human health functional food rules as they are. In the reviews of dogs and cats that this article confirmed, an effect of glucosamine and chondroitin was not confirmed.
The second misconception is the idea that “a US certification seal means the efficacy has been verified.” The NASC seal is a voluntary industry system indicating an industry group's audit and compliance with quality standards, and the standards the website describes do not include demonstration of joint efficacy.
The third misconception is the idea that “a supplement is not a drug, so there is no harm in giving a lot.” A supplement is also a substance that goes into the body, so it can vary depending on the medication being taken, chronic conditions, and old age. This article does not give a dose or frequency, and it should not be decided arbitrarily without the product instructions or a veterinary consultation.
The fourth misconception is the idea that “if you give a supplement, you can do less exercise and weight management.” The Merck Veterinary Manual explains that regular, controlled exercise reduces sensitivity to pain and strengthens the soft tissues around the joints. The materials this article confirmed contain no evidence that a supplement takes the place of these two.
The fifth misconception is the idea that “starting a joint supplement early prevents arthritis.” This article has no clinical evidence in dogs confirming a preventive effect. This means there is no evidence, not that it is stated that prevention is impossible.
Here are the things this article could not confirm, gathered in one place.
- Evidence for joint supplements in cats.
- The full text of individual clinical trial papers and new trials after 2022.
- Clinical evidence in dogs supporting cartilage protection, slowing of arthritis progression, or a preventive effect.
- The original text of the provisions of the Control of Livestock and Fish Feed Act (사료관리법) and the original Korea Consumer Agency press release.
This list does not mean there is no effect, but that this article could not confirm the evidence.
When to consult a veterinarian
If a pet limps, hesitates when getting up and lying down, avoids stairs and jumping, walks less, or dislikes having a joint area touched, getting a veterinary visit at an animal hospital comes before buying a supplement. The Merck Veterinary Manual lists limping, joint swelling, and muscle wasting as signs of osteoarthritis, and explains that a veterinarian chooses drugs according to the symptoms, age, and overall health. The cause of the pain may not be osteoarthritis, so a diagnosis is needed first.
A veterinarian provides, together with a pain assessment, a weight control plan, controlled exercise, and, where needed, methods such as drugs or surgery. The Merck Veterinary Manual's guidance for owners explains that nonsteroidal anti-inflammatory drugs reduce pain and inflammation, but long-term use can cause problems such as decreased appetite, vomiting, and gastrointestinal inflammation. If your pet is taking such a drug, you should consult a veterinarian before adding a supplement.
When you consult, bringing the names and ingredient labels of the food, treats, supplements, and drugs you are currently giving makes it easier to check for duplication. Whether the pet is eating food that already contains omega-3 is also important information. The criteria for choosing an omega-3 product itself are covered in another article (omega3-fish-oil-for-pets), so only the joint evidence is organized here.
In the following cases you should get a veterinary visit without delay: when the pet suddenly cannot put weight on a leg, when a joint is visibly swollen or warm, when appetite drops and vomiting or diarrhea appear together, and when the pet cries out badly in pain or its breathing becomes labored. Care signs for older dogs are covered in a separate article (senior-dog-care-signs), and this article does not replace a diagnosis or prescription.
Frequently asked questions
Q Does it mean glucosamine and chondroitin have no effect on a dog's joints?
The 2022 systematic review and meta-analysis reported that the pain-relieving effect of combined glucosamine-chondroitin products was very clearly absent, and said they are no longer recommended for pain management. However, this is a conclusion about clinical pain relief, and how they act in an individual pet should be discussed with a veterinarian.
Q Is there evidence that omega-3 helps joints?
The 2022 review reported distinct evidence of a pain-relieving effect for omega-3-enriched diets and omega-3 supplements, and the 2012 review also said that the strength of evidence for nutritional supplements other than omega-3 in dogs is low. However, the number and size of trials are limited, so it is hard to treat this as a definitive conclusion. Product choice is covered in a separate article.
Q If a product has the US NASC quality seal, is a joint effect proven?
No. The NASC website explains that the seal can be used on the basis of an external audit and compliance with quality standards, and this is a voluntary system of an industry group. The standards the website describes do not include demonstration of efficacy, and this article did not evaluate the efficacy of products that carry the seal.
Q In Korea, is a joint supplement a drug or feed?
MAFRA advises that an item intended to treat or prevent disease in animals is a veterinary drug. A specialist outlet in Korea reported that pet supplements are managed as feed, such as complementary feed, under the Control of Livestock and Fish Feed Act (사료관리법). For the text of the law, it is good to check the current provisions at the National Law Information Center.
Q If a supplement package says it treats arthritis, can I trust it?
MAFRA advises that in online sales it restricts expressions claiming to treat diseases such as joint disease and advertising of medical efficacy without evidence. According to the reported Korea Consumer Agency survey, 67 of 100 online advertisements emphasized disease prevention or treatment without scientific evidence. It is safer not to take such phrases at face value and to check with a veterinarian.
Q Which comes first, a supplement or weight management?
The Merck Veterinary Manual explains that optimizing body weight is the main preventive method for slowing the progression of osteoarthritis in dogs and is essential if the dog is overweight. It also says that regular, controlled exercise reduces sensitivity to pain. This article has no evidence that a supplement takes their place.
Q My pet is already taking medication. Can I give a supplement together with it?
This article does not judge doses or whether they can be combined. Some drugs, such as nonsteroidal anti-inflammatory drugs, can cause gastrointestinal problems with long-term use, so before adding or changing a supplement you should show the veterinarian the medication currently being taken and the product's ingredients and consult them.
Limits and scope of this guide
This article focuses on osteoarthritis in dogs, and the evidence for cats is not sufficient. The center of the evidence is the abstracts of the 2022 and 2012 systematic reviews checked on PubMed, and the Korean classification of supplements was checked through a media report and a MAFRA press release. Items that could not be confirmed are gathered at the end of the section “What are common misconceptions about joint supplements?” Cannabidiol and the Korean system are not covered, and doses and product comparisons are not made. The general information in this article may not suit young animals, pregnant or nursing animals, or animals with chronic conditions or prescription medication, and diagnosis and prescription are for the veterinarian.
Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.
Sources and check dates
- A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis (PubMed abstract) ↗
Used as the basis for the design of the systematic review of nutritional supplements for osteoarthritis in dogs and cats and the conclusions by ingredient (omega-3 evidence, effect of glucosamine and chondroitin not confirmed).
- Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis (PubMed abstract) ↗
Used as the basis for the conclusion of the 2012 review that the strength of evidence for nutritional supplements other than omega-3 in dogs is low and the number of trials is insufficient.
- FDA's Regulation of Pet Food ↗
Used as the basis for the explanation that animal supplements are not a separate category but are classified as animal food or animal drugs, and for the example of a joint-improving product.
- NASC Quality Seal (guide to the quality seal) (품질 인증 표시 안내) ↗
Used as the basis for the explanation that the NASC quality seal rests on independent audits and its own quality standards (quality control manual, adverse event reporting, random product testing, and so on) (the industry group's own explanation; voluntary industry system).
- A guide to using veterinary drugs correctly (동물용의약품 올(ALL)바르게 안내) ↗
Used as the basis for the definition of veterinary drugs and the guidance prohibiting expressions about treating diseases such as joint disease and exaggerated advertising in online sales. The page body contained only an attached card news (image), so I opened that image to check it.
- Pet supplements need an ingredient list and an expert review system (반려동물 영양제·보조제, 성분 목록 및 전문가 검토 체계 필요) ↗
Used as the basis for how pet supplements are currently managed under the Control of Livestock and Fish Feed Act (사료관리법) and for the reported content of the Korea Consumer Agency survey (20 supplements, 100 advertisements) (media report; the first author of the paper the article covered is a researcher affiliated with the Korea Pet Food Association).
- We will further strengthen distribution management of pet food (press release) (반려동물 사료 유통관리를 더욱 강화해 나가겠습니다(보도자료)) ↗
Used as the basis for the guidance that under current law pet food is not classified separately as supplements and the like, but is divided under the Control of Livestock and Fish Feed Act (사료관리법) into single-ingredient, complementary, and formula feed.
- Degenerative joint disease(osteoarthritis) in dogs and cats (professional version) (전문가용) ↗
Used as the basis for the guidance that optimizing body weight and controlled exercise come first and for the summary of evidence on nutritional supplements.
- Arthritis in dogs (owner version) (보호자용) ↗
Used as the basis for the treatment guidance for owners (weight management, gastrointestinal problems with long-term use of anti-inflammatory painkillers, the veterinarian's choice of drugs).
Korean edition checked · translated · each source may have a different check date. No paid partnerships.
This guide relies on 1 Korean law or notice. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.
